NX Prenatal

Curated by Signal

Provider of early warning blood tests for pregnancy complications

Overview

Provider of early warning blood tests for pregnancy complications. The company's assays leverage its proprietary NeXosome platform technology which enables the isolation and enrichment of exosome and microvesicle particles from bodily fluids for non-invasive biomarker evaluation.

Key facts

Founded: 2010
Headquarters: Louisville, United States
Stage: Sign up to view
Industry: Life Sciences Technology

Business model

4 products and services: Sign up to view

Contact

Primary office: Sign up to view
Email: Sign up to view
Phone: Sign up to view

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Life Sciences Technology companies

NeuroLight
Developer of electroencephalography or brain imaging devices
Life Sciences TechnologySuffern, United States
Fluxergy
Provider of a portable platform for biomarker detection
Life Sciences TechnologyIrvine, United States
Advarra
Provider of regulatory compliance consulting services
Life Sciences TechnologyColumbia, United States

About NX Prenatal

What does NX Prenatal do?

Provider of early warning blood tests for pregnancy complications.

Where is NX Prenatal headquartered?

NX Prenatal is headquartered in Louisville, United States.

When was NX Prenatal founded?

NX Prenatal was founded in 2010.

Which sector is NX Prenatal in?

NX Prenatal operates in Life Sciences Technology.

Who are NX Prenatal's competitors?

Companies similar to NX Prenatal include NeuroLight, Fluxergy, and Advarra.